SEC Form 4 · accession 0001209191-18-025011
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Demski
Officer — Chief Executive Officer · Director
Period of report
Apr 12, 2018
Accepted (ET)
Apr 16, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001237831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Apr 12, 2018 | M | 3,846 | $10.66 | A | 152,701 | D | |
| Class A Common Stock | Apr 12, 2018 | S | 3,846 | $51.00 | D | 148,855 | D | |
| Class A Common Stock | Apr 12, 2018 | M | 28,333 | $13.04 | A | 177,188 | D | |
| Class A Common Stock | Apr 12, 2018 | S | 28,333 | $51.00 | D | 148,855 | D | |
| Class A Common Stock | Apr 12, 2018 | M | 6,875 | $15.34 | A | 155,730 | D | |
| Class A Common Stock | Apr 12, 2018 | S | 6,875 | $51.00 | D | 148,855 | D | |
| Class A Common Stock | Apr 12, 2018 | M | 8,794 | $23.95 | A | 157,649 | D | |
| Class A Common Stock | Apr 12, 2018 | S | 8,794 | $51.00 | D | 148,855 | D | |
| Class A Common Stock | Apr 13, 2018 | M | 3,043 | $23.95 | A | 151,898 | D | |
| Class A Common Stock | Apr 13, 2018 | S | 3,043 | $51.00 | D | 148,855 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $10.66 | Apr 12, 2018 | M | 3,846 | D | — | Oct 27, 2021 | Class A Common Stock | 3,846 | 0 | D |
| Stock Option (Right to Buy Class A Common Stock)F3 | $13.04 | Apr 12, 2018 | M | 28,333 | D | — | Jan 24, 2023 | Class A Common Stock | 28,333 | 0 | D |
| Stock Option (Right to Buy Class A Common Stock)F4 | $15.34 | Apr 12, 2018 | M | 6,875 | D | — | Aug 29, 2022 | Class A Common Stock | 6,875 | 0 | D |
| Stock Option (Right to Buy Class A Common Stock)F5 | $23.95 | Apr 12, 2018 | M | 8,794 | D | — | Jan 23, 2024 | Class A Common Stock | 8,794 | 46,206 | D |
| Stock Option (Right to Buy Class A Common Stock)F5 | $23.95 | Apr 13, 2018 | M | 3,043 | D | — | Jan 23, 2024 | Class A Common Stock | 3,043 | 43,163 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
- F2These options were granted on October 27, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
- F3These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
- F4These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
- F5These options were granted on January 23, 2014, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.